However, some researchers reported that T-ALL patients with NOTCH1/FBXW7 mutations had better OS when compared with wild-type cases (5, 27, 37), and NOTCH1 mutations predicted a faster early treatment response (38). Here, NOTCH1 is linked to acute lymphoblastic leukemia.